ADIAL PHARMACEUTICALS, INC. (ADIL) SEC Filings & Financial Intelligence
ADIAL PHARMACEUTICALS, INC. (ADIL) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ADIL
CIK: 1513525
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
CBIZ CPAs P.C.
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerSviatlana LiPuma
Audit LocationMarlton, New Jersey, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| DEFA14A | 2026-10-16 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-110352 | View SEC Doc Filr Page |
| 8-K | 2026-10-16 | 2026-10-15 | CURRENT REPORT | 0001213900-26-110349 | View SEC Doc Filr Page |
| DEFA14A | 2026-10-05 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-106577 | View SEC Doc Filr Page |
| 8-K | 2026-10-02 | 2026-10-01 | CURRENT REPORT | 0001213900-26-106395 | View SEC Doc Filr Page |
| 4 | 2026-09-21 | 2026-09-17 | 4 Filing | 0001213900-26-101883 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-18 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-101500 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-17 | CURRENT REPORT | 0001213900-26-101434 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-16 | — | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-100607 | View SEC Doc Filr Page |
| 8-K | 2026-09-16 | 2026-09-16 | CURRENT REPORT | 0001213900-26-100574 | View SEC Doc Filr Page |
| S-3 | 2026-08-28 | — | REGISTRATION STATEMENT | 0001213900-26-095122 | View SEC Doc Filr Page |
| S-8 | 2026-08-28 | — | REGISTRATION STATEMENT | 0001213900-26-095119 | View SEC Doc Filr Page |
| 8-K | 2026-08-25 | 2026-08-19 | CURRENT REPORT | 0001213900-26-093544 | View SEC Doc Filr Page |
| ARS | 2026-08-24 | 2025-12-31 | FORM ARS | 0001213900-26-093022 | View SEC Doc Filr Page |
| DEF 14A | 2026-08-24 | 2026-09-17 | PROXY STATEMENT | 0001213900-26-093019 | View SEC Doc Filr Page |
| 8-K | 2026-08-21 | 2026-08-18 | CURRENT REPORT | 0001213900-26-092690 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-17 | CURRENT REPORT | 0001213900-26-090482 | View SEC Doc Filr Page |
| 10-Q | 2026-08-14 | 2026-06-30 | QUARTERLY REPORT | 0001213900-26-090051 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-10 | CURRENT REPORT | 0001213900-26-089270 | View SEC Doc Filr Page |
| PRE 14A | 2026-08-11 | 2026-08-10 | PROXY STATEMENT | 0001213900-26-087445 | View SEC Doc Filr Page |
| 8-K/A | 2026-08-11 | 2026-06-11 | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-087439 | View SEC Doc Filr Page |
| 4 | 2026-07-16 | 2026-07-14 | OWNERSHIP DOCUMENT | 0001104659-26-084300 | View SEC Doc Filr Page |
| 4 | 2026-07-13 | 2026-07-09 | OWNERSHIP DOCUMENT | 0001104659-26-082972 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-07-01 | — | SCHEDULE 13G/A Filing | 0001104659-26-079983 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | OWNERSHIP DOCUMENT | 0001104659-26-079686 | View SEC Doc Filr Page |
| 3 | 2026-06-29 | 2026-06-24 | OWNERSHIP DOCUMENT | 0001104659-26-078710 | View SEC Doc Filr Page |